Q&A: How Walgreens is helping fight the HIV epidemic
Walgreens has long been working to combat the HIV epidemic. In addition to specially training its pharmacists to offer compassionate and confidential HIV care with a focus on treatment as prevention, the company also focuses on HIV testing and participates in the U.S. Department of Health and Human Services’ Ready, Set, PrEP program, with the ability to dispense pre-exposure prophylaxis, or PrEP medications from all of its pharmacies nationwide. Drug Store News caught up with Brad McElya, Walgreens director of specialty health solutions, to talk about the company’s HIV efforts and what they have looked like throughout the pandemic.
DSN: What role does education play in combating HIV and what is Walgreen’s role in educating patients about the epidemic?
BM: When it comes to HIV, there are some nuances. We know that, for instance, 1 in 7 individuals in the United States do not know that they are living with HIV. That's why we're really trying to increase the focus around HIV testing, because if a patient does not know their HIV status, then they can't get into treatment or they wouldn't be able to take PrEP as it is one of the requirements. Secondly, when it comes to PrEP, many patients may not be aware of what they need to do in order to take their healthcare into their own hands. It’s up to us to help inform patients that they can take this medication and it can actually prevent them from acquiring HIV. In our ‘treatment as prevention approach,’ I believe that we have a key role in helping patients afford their medications, to remain adherent, knowing that if we do that, then we can help the patient's viral load be suppressed and therefore they would not transmit HIV to another individual.